{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-061608","form_type":"8-K","ticker":"IVVD","cik":"0001832038","company_name":"Invivyd, Inc.","filed_at":"2022-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.660068+00:00","generated_at":"2026-06-27T03:11:59.775283+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Adagio CMO Lynn Connolly resigns; Hershberger takes over clinical development","bullets":["CMO Lynn Connolly resigns effective March 25, 2022, to tend to family obligations.","Connolly remains through ADG20 Phase 2/3 data analysis and transition of duties.","Chief Development Officer Ellie Hershberger permanently assumes responsibility for clinical development programs.","Company expects to enter into a consulting agreement with Dr. Connolly."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-061608","json":"https://secwatch.observer/filing/0001193125-22-061608.json","markdown":"https://secwatch.observer/filing/0001193125-22-061608.md","text":"https://secwatch.observer/filing/0001193125-22-061608.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832038/000119312522061608/0001193125-22-061608-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832038/000119312522061608/d656486d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T03:11:59.775283+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dc5a03a8cc","claim":"Lynn Connolly resigned as Chief Medical Officer at Invivyd, Inc..","evidence_excerpt":"Lynn Connolly, M.D., Ph.D., Chief Medical Officer of Adagio Therapeutics, Inc. (the “Company”), has resigned her position, effective as of March 25, 2022, to tend to family obligations.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832038/000119312522061608/0001193125-22-061608-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}